Sujal M. Patel - Mar 19, 2025 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CEO, President, and Secretary, Director, 10%+ Owner
Signature
/s/ Mathew B. Murphy, as Attorney-in-Fact
Stock symbol
NAUT
Transactions as of
Mar 19, 2025
Transactions value $
$76,918
Form type
4
Date filed
3/21/2025, 04:44 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $53K +53.3K +0.53% $0.99 10.1M Mar 19, 2025 Direct F1
transaction NAUT Common Stock Purchase $23.9K +23.9K +0.24% $1.00 10.1M Mar 20, 2025 Direct F2
holding NAUT Common Stock 1.81M Mar 19, 2025 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F3
holding NAUT Common Stock 5.28M Mar 19, 2025 By PFV I, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 53,300 shares purchased in the price range of $0.9469 to $1.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 23,933 shares purchased in the price range of $0.9351 to $1.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
F4 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.